Du är nu på väg att lämna en GSK-hemsida

Denna länk leder till en hemsida som inte tillhör GSK. GSK tar inget ansvar för innehållet på tredje parts hemsidor.



Using biologics


We are moving away from the traditional characterisation of severe asthma and towards the promise of biomarker-guided, phenotype-specific therapies. Inside Severe Asthma shares the latest information so you can explore how these advances will be clinically relevant to you. With access to a collection of the latest publications and videos of what the experts are saying, find out how this will advance future treatment choices in severe asthma.

In this section:

About biologics

Biologics for severe asthma

Eosinophils, IL-5 and their role in severe asthma

Eosinophils as markers for treatment